BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36882122)

  • 21. The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.
    Argüeso P; Tisdale A; Mandel U; Letko E; Foster CS; Gipson IK
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):86-92. PubMed ID: 12506059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages.
    da Costa Santos MAR; Dos Reis JS; do Nascimento Santos CA; da Costa KM; Barcelos PM; de Oliveira Francisco KQ; Barbosa PAGN; da Silva EDS; Freire-de-Lima CG; Morrot A; Decote-Ricardo D; Diniz-Lima I; Previato JO; Mendonca-Previato L; da Fonseca LM; Freire-de-Lima L
    Immunol Res; 2023 Feb; 71(1):92-104. PubMed ID: 36197587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
    Matsuura H; Takio K; Titani K; Greene T; Levery SB; Salyan ME; Hakomori S
    J Biol Chem; 1988 Mar; 263(7):3314-22. PubMed ID: 2449438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
    Gerken TA; Revoredo L; Thome JJ; Tabak LA; Vester-Christensen MB; Clausen H; Gahlay GK; Jarvis DL; Johnson RW; Moniz HA; Moremen K
    J Biol Chem; 2013 Jul; 288(27):19900-14. PubMed ID: 23689369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
    Miyahara N; Shoda J; Kawamoto T; Furukawa M; Ueda T; Todoroki T; Tanaka N; Matsuo K; Yamada Y; Kohno K; Irimura T
    Clin Cancer Res; 2004 Mar; 10(6):2090-9. PubMed ID: 15041730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
    Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
    Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
    Li Z; Yamada S; Inenaga S; Imamura T; Wu Y; Wang KY; Shimajiri S; Nakano R; Izumi H; Kohno K; Sasaguri Y
    Br J Cancer; 2011 Jun; 104(12):1882-9. PubMed ID: 21587259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells.
    Alisson-Silva F; Freire-de-Lima L; Donadio JL; Lucena MC; Penha L; Sá-Diniz JN; Dias WB; Todeschini AR
    PLoS One; 2013; 8(4):e60471. PubMed ID: 23593224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O-glycosylation potential of lepidopteran insect cell lines.
    Lopez M; Tetaert D; Juliant S; Gazon M; Cerutti M; Verbert A; Delannoy P
    Biochim Biophys Acta; 1999 Mar; 1427(1):49-61. PubMed ID: 10082987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-GalNAc incorporation into a cluster acceptor site of three consecutive threonines. Distinct specificity of GalNAc-transferase isoforms.
    Takeuchi H; Kato K; Hassan H; Clausen H; Irimura T
    Eur J Biochem; 2002 Dec; 269(24):6173-83. PubMed ID: 12473113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells.
    Chen YJ; Kuo CD; Chen SH; Chen WJ; Huang WC; Chao KS; Liao HF
    PLoS One; 2012; 7(5):e37006. PubMed ID: 22615870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 in early gastric carcinoma.
    Ishikawa M; Kitayama J; Nariko H; Kohno K; Nagawa H
    J Surg Oncol; 2004 Apr; 86(1):28-33. PubMed ID: 15048677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.
    Bennett EP; Hassan H; Mandel U; Mirgorodskaya E; Roepstorff P; Burchell J; Taylor-Papadimitriou J; Hollingsworth MA; Merkx G; van Kessel AG; Eiberg H; Steffensen R; Clausen H
    J Biol Chem; 1998 Nov; 273(46):30472-81. PubMed ID: 9804815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to cisplatin in human lung adenocarcinoma cells: effects on the glycophenotype and epithelial to mesenchymal transition markers.
    da Fonseca LM; da Silva VA; da Costa KM; Dos Reis JS; Previato JO; Previato LM; Freire-de-Lima L
    Glycoconj J; 2022 Apr; 39(2):247-259. PubMed ID: 35156157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).
    Kubota T; Shiba T; Sugioka S; Furukawa S; Sawaki H; Kato R; Wakatsuki S; Narimatsu H
    J Mol Biol; 2006 Jun; 359(3):708-27. PubMed ID: 16650853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct orders of GalNAc incorporation into a peptide with consecutive threonines.
    Kato K; Takeuchi H; Miyahara N; Kanoh A; Hassan H; Clausen H; Irimura T
    Biochem Biophys Res Commun; 2001 Sep; 287(1):110-5. PubMed ID: 11549261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNAs targeting multidrug transporter genes sensitise breast tumour to doxorubicin in a syngeneic mouse model.
    Tiash S; Chowdhury EH
    J Drug Target; 2019 Mar; 27(3):325-337. PubMed ID: 30221549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excess APP O-glycosylation by GalNAc-T6 decreases Aβ production.
    Akasaka-Manya K; Kawamura M; Tsumoto H; Saito Y; Tachida Y; Kitazume S; Hatsuta H; Miura Y; Hisanaga SI; Murayama S; Hashimoto Y; Manya H; Endo T
    J Biochem; 2017 Jan; 161(1):99-111. PubMed ID: 28053144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
    Wu C; Guo X; Wang W; Wang Y; Shan Y; Zhang B; Song W; Ma S; Ge J; Deng H; Zhu M
    BMC Cancer; 2010 Apr; 10():123. PubMed ID: 20356418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.